DIA Names Barbara Lopez Kunz Global Chief Executive

Worldwide Life Sciences Business Leader to Bring New Vision and Momentum to DIA

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

DIA log

Horsham, Pa. (PRWEB) July 29, 2013

DIA today announced that Barbara Lopez Kunz has been named global chief executive, leading the organization as of Sept. 1, 2013. Kunz brings exceptional worldwide leadership experience to DIA as former president of the Global Health and Life Sciences business at Battelle, an international science and technology nonprofit organization that explores emerging areas of science, develops and commercializes technology and manages laboratories.

“DIA is excited to welcome an internationally respected leader who mirrors our vision—to be the global forum fostering innovation to raise the level of health and well-being worldwide,” DIA President Minnie Baylor-Henry said. “Barbara has a remarkably successful track record of growing businesses that are based on innovation in science and technology and implementing globally effective strategies, and we are looking forward to her leadership and guidance.”

In her role with Battelle, Kunz transformed the Global Health and Life Sciences through strategic investments, alliance development and technology commercialization, increasing the number of research collaborations with industrial, government and academic sponsors. She has also held senior roles at Thermo Fisher Scientific (formerly Fisher Scientific International), Croda International (formerly Uniqema), DuPont and PPG Industries, after starting her career as a research scientist.

A leader on numerous corporate and nonprofit boards, she has presided over the board of The Ohio State University Wexner Medical Center and is a trustee of both the Nationwide Children’s Hospital research institute and BioOhio, the statewide organization stimulating economic development in the bioscience community. Kunz is a member of the Healthcare Businesswomen’s Association Ohio chapter advisory board.

“I look forward to continuing to advance innovation worldwide as I lead DIA into its 50th year. The foundation is in place to use my global knowledge of patient needs and the health care community to fortify DIA’s significant role in transferring vital information across the globe,” Kunz said.

For more information, please go to http://www.diahome.org. To arrange an interview with Kunz or to request a headshot or complete biography, please contact Eric Rosen at 215.290.9153 or eric.rosen(at)diahome(dot)org.

ABOUT DIA: DIA is a neutral, global, professional and member-driven association of nearly 18,000 professionals involved in the discovery, development and life cycle management of pharmaceuticals, biotechnology, medical devices and related health care products. Through our international educational offerings and myriad networking opportunities, DIA provides a global forum for knowledge exchange that fosters the innovation of products, technologies and services to improve health and well-being worldwide. Headquarters are in Horsham, Pa., USA, with offices in Basel, Switzerland; Tokyo, Japan; Mumbai, India; Beijing, China; Washington, D.C.; and Latin America. Visit our website at http://www.diahome.org and follow DIA at: LinkedIn, Twitter, YouTube, Facebook, Flickr, and Pinterest.

###